Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand.

By P. Pitisuttithum, Peter B. Gilbert, M. Gurwith, W. Heyward, Michael Martin, Fritz van Griensven, D. Hu, J. Tappero, K. Choopanya. Journal of Infectious Diseases, 2006

858 citations recorded by the source corpus.

Subfields: Infectious Diseases, Virology

View Paper: https://www.semanticscholar.org/paper/ce74390a2186ef015bc981772a76a27ec3195da2

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Infectious Diseases

1. Ian A. Wilson
2. Abdo A. Elfiky

Citations in the corpus

• A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies (2013, background): “Of these, the most widely tested have been monomeric gp120 subunits, which failed to induce bNAbs and did not prevent infection [2,3,4].”